» Articles » PMID: 15695497

Depression and Anxiety in Women with Early Breast Cancer: Five Year Observational Cohort Study

Overview
Journal BMJ
Specialty General Medicine
Date 2005 Feb 8
PMID 15695497
Citations 398
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the prevalence of, and risk factors for, depression and anxiety in women with early breast cancer in the five years after diagnosis.

Design: Observational cohort study.

Setting: NHS breast clinic, London.

Participants: 222 women with early breast cancer: 170 (77%) provided complete interview data up to either five years after diagnosis or recurrence.

Main Outcome Measures: Prevalence of clinically important depression and anxiety (structured psychiatric interview with standardised diagnostic criteria) and clinical and patient risk factors, including stressful life experiences (Bedford College life events and difficulties schedule).

Results: Nearly 50% of the women with early breast cancer had depression, anxiety, or both in the year after diagnosis, 25% in the second, third, and fourth years, and 15% in the fifth year. Point prevalence was 33% at diagnosis, falling to 15% after one year. 45% of those with recurrence experienced depression, anxiety, or both within three months of the diagnosis. Previous psychological treatment predicted depression, anxiety, or both in the period around diagnosis (one month before diagnosis to four months after diagnosis). Longer term depression and anxiety, were associated with previous psychological treatment, lack of an intimate confiding relationship, younger age, and severely stressful non-cancer life experiences. Clinical factors were not associated with depression and anxiety, at any time. Lack of intimate confiding support also predicted more protracted episodes of depression and anxiety.

Conclusion: Increased levels of depression, anxiety, or both in the first year after a diagnosis of early breast cancer highlight the need for dedicated service provision during this time. Psychological interventions for women with breast cancer who remain disease free should take account of the broader social context in which the cancer occurs, with a focus on improving social support.

Citing Articles

Sociodemographic Factors and Depression in Patients With Breast Cancer: A Multicenter, Cross-sectional Study in Georgia.

Kakhniashvili T, Okribelashvili N, Kiladze I Breast Cancer (Auckl). 2025; 19:11782234251323775.

PMID: 40078466 PMC: 11898038. DOI: 10.1177/11782234251323775.


Effects of Exercise on Depression and Anxiety in Breast Cancer Survivors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Zhang Y, Li G, Zhang S, Zhou Y, Lv Y, Feng L Cancer Med. 2025; 14(5):e70671.

PMID: 40052614 PMC: 11886893. DOI: 10.1002/cam4.70671.


Prevalence and associated factors of psychological distress among patients with oral cancer in the selected tertiary care institutes in Sri Lanka: a combined cross-sectional and case-control study.

Ratnasekera N, Perera I, Kandapola Arachchige P, Perera S, Jayasekara P BMJ Public Health. 2025; 3(1):e001638.

PMID: 40051540 PMC: 11883870. DOI: 10.1136/bmjph-2024-001638.


Development and Validation of a Predictive Model for Anxiety Trajectories in Patients with Breast Cancer: A Retrospective Study.

Li X, Wei B, Li F, Yan H, Shen J Psychol Res Behav Manag. 2025; 18:315-329.

PMID: 39980876 PMC: 11840338. DOI: 10.2147/PRBM.S501127.


Depression in pregnant non-diabetic women and women with gestational diabetes in Bangladesh-a comparative study based on multiple logistic regression.

Fatimah K Diabetol Int. 2025; 16(1):115-122.

PMID: 39877449 PMC: 11769880. DOI: 10.1007/s13340-024-00777-8.


References
1.
OShaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub J, Cervantes G . Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol. 2002; 20(12):2812-23. DOI: 10.1200/JCO.2002.09.002. View

2.
Ganz P, Desmond K, Leedham B, Rowland J, Meyerowitz B, Belin T . Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002; 94(1):39-49. DOI: 10.1093/jnci/94.1.39. View

3.
Hughson A, Cooper A, McArdle C, Smith D . Psychological impact of adjuvant chemotherapy in the first two years after mastectomy. Br Med J (Clin Res Ed). 1986; 293(6557):1268-71. PMC: 1342107. DOI: 10.1136/bmj.293.6557.1268. View

4.
Fallowfield L, Baum M, Maguire G . Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Br Med J (Clin Res Ed). 1986; 293(6558):1331-4. PMC: 1342050. DOI: 10.1136/bmj.293.6558.1331. View

5.
Dean C . Psychiatric morbidity following mastectomy: preoperative predictors and types of illness. J Psychosom Res. 1987; 31(3):385-92. DOI: 10.1016/0022-3999(87)90059-6. View